Modern Pediatrics. Ukraine. 1(113): 62-67. doi 10.15574/SP.2021.113.62
Mochulska O. M., Kosovska T. M.
Ternopil National Medical University named after I.Ya. Horbachevsky, Ministry of Health Care in Ukraine

For citation: Mochulska OM, Kosovska TM. (2021). Systemic therapy of allergic dermatosis in children (literature review). Modern Pediatrics. Ukraine. 1(113): 62–67. doi 10.15574/SP.2021.113.62
Article received: Nov 11, 2020. Accepted for publication: Feb 15, 2021.

Allergic pathology of skin is one of the most pressing problems of modern pediatry. The most common allergic dermatoses: simple and allergic contact dermatitis, atopic dermatitis, various forms of eczema, acute and chronic allergic urticaria, Quincke's edema, toxicodermias, multiforme exudative erythema (Stevens-Johnson syndrome), acute epidermal necrolysis (Lyell's syndrome). Many aspects of systemic treatment of allergic dermatoses in children are complex and controversial. The modern strategy of treatment of allergic dermatoses in children is based on the principles of evidence-based medicine. According to the international program documents EAACI (European Academy of Allergy and Clinical Immunology), AAAAI (American Academy of Allergy, Asthma & Immunology), PRACТALL (Practical Allergology Consensus Report) treatment of allergic dermatoses consists of: environmental control to eliminate allergenic and non-allergenic factors, skin care, systemic and local pharmacotherapy. Systemic pharmacotherapy includes using drugs of the following groups: antihistamines, glucocorticosteroids, membrane's stabilizators (kromons), leukotriene receptor antagonists, anti-IgE, cytostatics, sorbents, hepatoprotectors, probiotics, vitamins and minerals, antioxidants, sedative medications, enzymes, antibacterial, antifungal and antiviral, immunomodulatory and immunosuppressive medications.
Purpose — to increase information on modern possibilities of systemic therapy of allergic dermatoses in children.
Conclusions. Systemic pharmacotherapy of allergic dermatoses should be etiopathogenetic and influence the systemic mechanisms of allergic inflammation, which will help control the clinical course of the disease, reduce disability, improve the life quality of patients.
No conflict of interest was declared by the authors.
Key words: children, allergy, allergic dermatoses, systemic therapy, internal therapy.

REFERENCES

1. Akan A, Dibek Misirlioglu E, Civelek E, Vezir E, Kocabas CN. (2020). Diagnosis of atopic dermatitis in children: comparison of the Hanifin-Rajka and the United Kingdom Working Party criteria. Allergologia et Immunopathologia. 48 (2): 175-181. URL: http://www.sciencedirect.com/science/article/pii/S0301054619301156. https://doi.org/10.1016/j.aller.2019.07.008; PMid:31611041

2. Beltrani VS. (1998). Allergic Dermatoses. Medical Clinics of North America. 82 (5): 1105-1133. URL: http://www.sciencedirect.com/science/article/pii/S0025712505704053. https://doi.org/10.1016/S0025-7125(05)70405-3

3. Bourrain JL. (2017). Toxicodermias. EMC – Dermatologia. 51 (4): 1-13. URL: http://www.sciencedirect.com/science/article/pii/S1761289617870527. https://doi.org/10.1016/S1761-2896(17)87052-7

4. Dowling PJ, Kader R, Portnoy JM. (2019). COLA (Conferences On-Line Allergy) at 10 Years – Evolution of an Online Fellowship Curriculum. The Journal of Allergy and Clinical Immunology: In Practice. 7 (8): 2568-2573. URL: http://www.sciencedirect.com/science/article/pii/S2213219819305975. https://doi.org/10.1016/j.jaip.2019.06.025; PMid:31279862

5. Fawbert K, Leech S. (2020). Recurrent urticaria and angioedema. Paediatrics and Child Health. 30 (7): 243-248. URL: http://www.sciencedirect.com/science/article/pii/S175172222030072X. https://doi.org/10.1016/j.paed.2020.04.001

6. Hsu DY, Brieva J, Silverberg NB, Paller AS, Silverberg JI. (2017). Pediatric Stevens-Johnson syndrome and toxic epidermal necrolysis in the United States. Journal of the American Academy of Dermatology. 76 (5): 811-817. URL: http://www.sciencedirect.com/science/article/pii/S0190962216312853. https://doi.org/10.1016/j.jaad.2016.12.024; PMid:28285784 PMCid:PMC5502094

7. Millan GG, Lopez Bran E. (2018). Toxicodermias. Medicine Programa de Formacion Medica Continuada Acreditado. 12 (48): 2846-2853. URL: http://www.sciencedirect.com/science/article/pii/S0304541218300076. https://doi.org/10.1016/j.med.2018.01.007

8. Napolitano M, Fabbrocini G, Patruno C. (2019). Allergic contact dermatitis in patients with atopic dermatitis: A retrospective study. The Journal of Allergy and Clinical Immunology: In Practice. 7 (7): 2459-2461. URL: http://www.sciencedirect.com/science/article/pii/S2213219819303307. https://doi.org/10.1016/j.jaip.2019.03.045; PMid:30954642

9. Nassau S, Fonacier L. (2020). Allergic Contact Dermatitis. Medical Clinics of North America. 04 (1): 61-76. URL: http://www.sciencedirect.com/science/article/pii/S0025712519300884. https://doi.org/10.1016/j.mcna.2019.08.012; PMid:31757238

10. Nguyen V, Simon L, Jaqua E. (2016). Allergic Dermatoses. Primary Care: Clinics in Office Practice. 43 (3): 433-449. URL: http://www.sciencedirect.com/science/article/pii/S0095454316300239. https://doi.org/10.1016/j.pop.2016.04.011; PMid:27545733

11. Noe MH, Micheletti RG. (2020). Diagnosis and management of Stevens-Johnson syndrome/toxic epidermal necrolysis. Clinics in Dermatology. 6: 738-744. URL: http://www.sciencedirect.com/science/article/pii/S0738081X20301498. https://doi.org/10.1016/j.clindermatol.2020.06.016; PMid:33341195

12. Ozceker D, Haslak F, Dilek F, Sipahi S, Yucel E, Guler N, Tamay Z. (2019). Contact sensitization in children with atopic dermatitis. Allergologia et Immunopathologia. 47 (1): 47-51. URL: http://www.sciencedirect.com/science/article/pii/S0301054618301009. https://doi.org/10.1016/j.aller.2018.06.002; PMid:30193890